The global hemodynamic monitoring devices market is anticipated to reach over USD 1523.65 Million by 2025 according to a new research published by Polaris Market Research.
The hemodynamic monitoring devices are majorly used for the medical analysis of cardiac health, quality, and durability of life of individuals suffering and recovering from cardiovascular surgery. These parameters are measured using photometric, electrical, pressure transducing equipment and invasive and noninvasive devices. The hemodynamic monitoring system also involves a use of various intravascular catheters.
The global hemodynamic monitoring devices market is majorly driven by growing demand for the analysis of critical congenital heart disease (CCHD), growing occurrence of respiratory disease, increasing incidence of lifestyle-related diseases, rising private as well as government sector initiatives to decrease healthcare costs and growing geriatric patient population. Advancement in technology in noninvasive or minimally invasive methods used for hemodynamic monitoring are another factors driving the global hemodynamic monitoring devices market growth. In addition, continuous R&D efforts by market key players to comprehend life-threatening diseases leading to the development of effective treatment products are anticipated to mark a significant growth during the forecast period.
The global hemodynamic monitoring devices market is segmented on the basis of product, type, end use, and geography. On the basis of product, the global hemodynamic monitoring devices market is segmented into Monitoring systems and disposals. On the basis of monitoring systems, the global hemodynamic market is further segmented into Cardiac output monitors, Pulmonary artery catheters, and others. On the other hand, the disposables are further segmented into Probes, Airflow Sensors, and Circuits.
On the basis of type, the global hemodynamic monitoring devices market is segmented into Non-invasive Hemodynamic Monitoring System, Minimally Invasive Hemodynamic Monitoring System, and Invasive Hemodynamic Monitoring System. Non-invasive devices are expected to display the fastest growth during the forecast period majorly due to the growing product expansion and increasing demand for proper care by people for such technology. On the basis of end use the global hemodynamic monitoring devices market is segmented into hospitals and catheterization laboratories. In 2017, the hospital segment is estimated to dominate the market by end-use segment.
On the basis of region, the global hemodynamic monitoring devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global hemodynamic monitoring devices market. The dominance is majorly attributed to the high growth of sales in the U.S. for these devices. Moreover, growing assurance of specialists in the forthcoming non-invasive technologies is expected to aid in supporting this dominance during the forecast period. However, Asia Pacific is expected to dominate the global hemodynamic monitoring devices market during the forecast. The rising governmental focus on quality healthcare, increasing occurrences of cardiovascular ailments and growing geriatric population are the factors anticipated to significantly boost the hemodynamic monitoring devices market in the Asia Pacific.
Some major key players in global hemodynamic monitoring devices market include includes Deltex Medical, Edward Lifesciences, Philips Medical, GE Healthcare, Hemo Sapiens, Inc., OsypkaCardiotek GmbH, LiDCO, and Drager Medical GmbH among others.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: